Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,540 | -1,708 | 1,465 | -870 | -1,482 |
| Depreciation Amortization | 97 | 96 | 96 | 98 | 111 |
| Accounts receivable | -207 | -9 | -126 | 525 | -172 |
| Accounts payable and accrued liabilities | 173 | -517 | -316 | -1,595 | 608 |
| Other Working Capital | -1,008 | 47 | -640 | 7 | -99 |
| Other Operating Activity | 3,538 | 2,467 | 780 | 1,785 | 465 |
| Operating Cash Flow | $-2,946 | $377 | $1,259 | $-50 | $-571 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -68 | -82 | -6 | -5 | -8 |
| Purchase Of Investment | N/A | -1,206 | -535 | N/A | N/A |
| Purchase Sale Intangibles | -10 | -17 | -21 | -27 | -32 |
| Other Investing Activity | -3,660 | -17 | -21 | -27 | -32 |
| Investing Cash Flow | $-3,727 | $-1,305 | $-561 | $-31 | $-39 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 50 | 0 | N/A |
| Debt Repayment | N/A | -50 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 9,798 | 235 | 150 | 79 |
| Other Financing Activity | 500 | 400 | 0 | 0 | 0 |
| Financing Cash Flow | $500 | $10,148 | $285 | $150 | $79 |
| Beginning Cash Position | 10,368 | 1,147 | 165 | 96 | 627 |
| End Cash Position | 4,194 | 10,368 | 1,147 | 165 | 96 |
| Net Cash Flow | $-6,174 | $9,221 | $982 | $69 | $-531 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,946 | 377 | 1,259 | -50 | -571 |
| Capital Expenditure | -68 | -82 | -6 | -5 | -8 |
| Free Cash Flow | -3,014 | 295 | 1,253 | -54 | -578 |